The WHO estimates that by 2020, depression will be the leading cause of disability worldwide. Pax Neuroscience, Inc. is a clinical diagnostics company focused on development and commercialization of blood tests for depression diagnosis and for antidepressant response. These tests are based on novel protein biomarkers derived from hypothesis-driven data sets and early clinical results are promising.
View Top Employees from PAX Neuroscience Inc.Website | http://www.paxneuroscience.com |
Revenue | $4 million |
Employees | 6 (3 on RocketReach) |
Founded | 2009 |
Address | 1113 Juniper Ter, Glenview, Illinois 60025, US |
Phone | (847) 998-6883 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Customer Service, Business Services, Health Diagnostics, Health Care, Professional Services |
Web Rank | 29 Million |
Competitors | Eutropics, Geneuity Clinical Research Services, ImQuest BioSciences, Marin Biologic Laboratories, Notable |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular PAX Neuroscience Inc. employee's phone or email?
The PAX Neuroscience Inc. annual revenue was $4 million in 2024.
Mark Rasenick is the President, Chief Scientific Officer and Founder of PAX Neuroscience Inc..
3 people are employed at PAX Neuroscience Inc..
PAX Neuroscience Inc. is based in Glenview, Illinois.
The NAICS codes for PAX Neuroscience Inc. are [54, 54171, 5417, 541, 541714].
The SIC codes for PAX Neuroscience Inc. are [873, 87].